Prevalence of Stroke in Individuals with Sickle Cell Disease Pre- and during Hydroxyurea Uses: A Descriptive Cross-Sectional Study in Tanzania
Adv Hematol. 2024 Mar 19;2024:7950925. doi: 10.1155/2024/7950925. eCollection 2024.ABSTRACTSickle cell disease (SCD) is an inherited blood disorder that leads to a variety of complications, including stroke. The use of hydroxyurea (HU) is reported to lessen the frequency and burden of stroke in SCD patients. However, less is known about the prevalence of stroke in SCD patients pre- and during the use of HU in sub-Saharan African (SSA) countries. Therefore, the study assessed stroke prevalence before and during uses of hydroxyurea among SCD patients in Tanzania. A hospital-based descriptive cross-sectional study was conduct...
Source: Advances in Hematology - March 27, 2024 Category: Hematology Authors: Belinda Nestory Moshi Erick G Philipo Nancy F Kileo Joseph Matobo Emili Yondu Dionis Ikunda Daniel Kandonga Koga M Luhulla Manase Kilonzi Source Type: research
